Concept of Rasayana Therapy in Covid 19

Tikeshwar Darwate (1) , Shamli Hiware (2)
(1) Mahatma Gandhi Ayurved College Hospital and Research Centre, Salod (H), Wardha, Datta Meghe Institute Of medical Sciences (DU), Nagpur, Maharashtra, India, India ,
(2) Department Of Panchakarma, Mahatma Gandhi Ayurveda College Hospital & Research Centre, Salod (H), Wardha, DattaMeghe Institute Of Medical Sciences (DU), Nagpur, Maharashtra, India, India

Abstract

An Ayurveda is an ancient system of medicine. The primary purpose of Ayurveda is to maintain the health of healthy individuals and cure the disease of the diseased one. 'Rasayanchikitsa’ plays a vital role in keeping the health of an individual. Rasayanchikitsa also plays an essential role in infectious disease which spreads directly or indirectly from man to man, animal to animal or from the environment to animal or man. Rasayana promotes physical health, improve dhatus (tissues), acts as immunomodulation and rejuvenate the system. Rasayana, by its name, means obtaining good qualities of rasa & nourishing the rasadidhatus (tissues). The excellent quality of rasa directly governs the state of health of individuals. Rasayana therapy deals with the delaying process of ageing, prolongation of life and curing the disease. Acharya Sushruta says, "for better results, Rasayan therapy should be done after Panchakarma procedures like Vaman, Virechan and Basti depending on the individual's Vata, pitta and Kapha predominance. Strength, improving complexion, prolongation of life, energy, enhancing memory, immunity booster, etc. is obtained from Rasayan therapy. Rasayan drugs help by modulating the neuro-endocrine-immune system and also a rich source of antioxidants. Review of the role of rasayan in the prevention of new infectious disease like Covid 19.

Full text article

Generated from XML file

Authors

Tikeshwar Darwate
Shamli Hiware
shamlihiware57@gmail.com (Primary Contact)
Tikeshwar Darwate, & Shamli Hiware. (2020). Concept of Rasayana Therapy in Covid 19. International Journal of Research in Pharmaceutical Sciences, 11((SPL 1), 857–861. Retrieved from https://ijrps.com/home/article/view/1680

Article Details

No Related Submission Found